Moderna says flu vaccine showed promising results in phase three trial, paving path to approval

Moderna compared the flu vaccine, dubbed mRNA-1010, to a currently approved seasonal flu vaccine from GlaxoSmithKline called Fluarix. 

from Health and Science https://ift.tt/xtj8oi4
https://ift.tt/Xa6BAuE
https://ift.tt/98eZvhq